Skip to content
Politically.com Search all
Menu

2025 · 2nd Quarter (Apr 1 - June 30)

EMPOWER PHARMACY

Filed by FRONTLINE GOVERNMENT RELATIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-09-16 06:26:08 UTC.

Source-reported fields

Filing overview

Type
Registration
Posted
Apr 17, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
c5b7ba88-51dc-4c09-8945-2ed30346733e
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Engage with federal agencies, members of Congress and congressional committees impacting pharmaceutical compounding and patient health issues.

HCR · Health Issues

Engage with federal agencies, members of Congress and congressional committees impacting pharmaceutical compounding and patient health issues.

MED · Medical/Disease Research/Clinical Labs

Engage with federal agencies, members of Congress and congressional committees impacting pharmaceutical compounding and patient health issues.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.